Phase 2 Febrile Neutropenia Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

Phase II Study of QLC2519 in Pediatric Solid Tumor Participants

NeutropeniaFebrile Neutropenia (FN)Pediatric Malignant Solid Tumor

Qilu Pharmaceutical Co., Ltd.18 enrolled1 locationNCT07724756

Recruiting

Phase 2

Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN

Primary/Secondary PreventionHigh Risk for Febrile Neutropenia of Chemotherapy RegimensIntermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in Febrile Neutropenia

Henan Cancer Hospital1,076 enrolled1 locationNCT07187908

Completed

Phase 2

Paracetamol in febrile neutropenia feasibility study

Infection: febrile neutropenia after intensive chemotherapy

Malaghan Institute of Medical Research50 enrolled1 locationACTRN12613000601730